Generic of Novo’s GLP-1 arrives in Canada, a ‘test case for the world’

Analysts will be watching as a generic version of semaglutide—marketed by Novo Nordisk as Wegovy for weight loss—launches in Canada as a test case for future price erosion in the U.S.